Phase 1, Open-Label, Randomized, Single-Dose, 5-Way Crossover Pilot Bioavailability Study Comparing Eletriptan Oral Disintegrating Tablet Formulations A And B Administered With Or Without Water To Relpax Commercial Tablets Administered With Water.
Phase of Trial: Phase I
Latest Information Update: 24 Apr 2010
At a glance
- Drugs Eletriptan (Primary)
- Indications Migraine
- Focus Pharmacokinetics
- Sponsors Pfizer
- 20 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 20 May 2009 Actual end date (Apr 2009) added as reported by ClinicalTrials.gov.
- 29 Apr 2009 Additional location identified as reported by ClinicalTrials.gov.